A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT06793397 · Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder
The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with MDD.
PhasePhase 3
TypeInterventional
Age18 Years – 85 Years
WhereBirmingham, Alabama, United States + 66 more
SponsorCybin IRL Limited
▾Tap for detailsClick for full details — eligibility, all locations, contacts
67 sitesApply